Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity
Protocols of controlled ovarian hyper-stimulation (COH) require, as a crucial step, the identification of reliable predictors of ovarian reserve. Anti-Mullerian hormone (AMH) is one of the most reliable predictors of ovarian reserve but other factors including autoimmune thyroid diseases (ATD) have...
Gespeichert in:
| Veröffentlicht in: | Reproductive biology and endocrinology 2015-09, Vol.13 (1), p.106-106, Article 106 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 106 |
|---|---|
| container_issue | 1 |
| container_start_page | 106 |
| container_title | Reproductive biology and endocrinology |
| container_volume | 13 |
| creator | Magri, Flavia Schena, Lucia Capelli, Valentina Gaiti, Margherita Zerbini, Francesca Brambilla, Emanuela Rotondi, Mario De Amici, Mara Spinillo, Arsenio Nappi, Rossella E Chiovato, Luca |
| description | Protocols of controlled ovarian hyper-stimulation (COH) require, as a crucial step, the identification of reliable predictors of ovarian reserve. Anti-Mullerian hormone (AMH) is one of the most reliable predictors of ovarian reserve but other factors including autoimmune thyroid diseases (ATD) have been associated with reduced fertility and poor COH outcome. Aim of the present study was to evaluate the relationship between ATD and AMH, and their role on the outcome of COH.
The study group included 288 sub-fertile euthyroid women aged less than 40 years attending a single center for Reproductive Medicine. Among them, 55 were ATD-positive and 233 ATD-negative. The serum levels of AMH, FSH, LH, estradiol (E2), and TSH were measured before COH. The ratio between serum E2 concentration on the day of oocytes pick-up and the total dose of administered recombinant FSH (r-FSH) (E2/r-FSH ratio) was calculated.
The serum levels of AMH were significantly related to E2/r-FSH ratio, total dose of r-FSH and number of M II oocytes, both in ATD-positive and ATD-negative women. Within the low stratum of AMH levels, the presence of ATD did not further affect the outcome of COH. When the serum levels of AMH were in the high stratum, the presence of ATD significantly affected the E2/rFSH ratio, the total dose of r-FSH and the number of M II oocytes.
The probability of a poor response to COH is high, and independent from ATD, in women with low AMH serum levels. In women with a good ovarian reserve, as assessed by high AMH serum levels, the presence of ATD impairs the outcome of COH. |
| doi_str_mv | 10.1186/s12958-015-0103-3 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4578365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541506235</galeid><sourcerecordid>A541506235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-7099a6d3dcbbd16bea7df90e29532e99ecab1f960ea510744f0342a6c3f2ff7e3</originalsourceid><addsrcrecordid>eNptkt1r3SAYxsPYWLtuf8BuhrCb3aT1I9FkF4ND2Rd0FEp3LUZfG0uiZ2oOnP9-Zqfr2jJEFP09z8urT1W9JfiUkI6fJUL7tqsxacvErGbPqmPSCFGLjornD_ZH1auUbjGmGHf8ZXVEOeuJEOy4ihufXf1jmSaITnk0hjgHD0glpNA2gnE6h4iCRWGn_hAREsQdIOfR5uq6MCEHHab0EeUR0OiMgQKFCVZRHvcxOIPUkoOb58W7vH9dvbBqSvDmbj2pfn75fH3-rb64_Pr9fHNR65bjXAvc94obZvQwGMIHUMLYHkNpmVHoe9BqILbnGFRLsGgai1lDFdfMUmsFsJPq08F3uwwzGA0-RzXJbXSzinsZlJOPb7wb5U3YyaYVHeNtMfhwZxDDrwVSlrNLGqZJeQhLkkQQ0QjaEFrQ90_Q27BEX9orVIdp29Gu-0fdqAmk8zaUuno1lZu2IS3mlK1lT_9DlWFgdrp8jnXl_JGAHAQ6hpQi2PseCZZrUOQhKLIERa5Bkaxo3j18nHvF32Sw3-FfudQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780258288</pqid></control><display><type>article</type><title>Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Magri, Flavia ; Schena, Lucia ; Capelli, Valentina ; Gaiti, Margherita ; Zerbini, Francesca ; Brambilla, Emanuela ; Rotondi, Mario ; De Amici, Mara ; Spinillo, Arsenio ; Nappi, Rossella E ; Chiovato, Luca</creator><creatorcontrib>Magri, Flavia ; Schena, Lucia ; Capelli, Valentina ; Gaiti, Margherita ; Zerbini, Francesca ; Brambilla, Emanuela ; Rotondi, Mario ; De Amici, Mara ; Spinillo, Arsenio ; Nappi, Rossella E ; Chiovato, Luca</creatorcontrib><description>Protocols of controlled ovarian hyper-stimulation (COH) require, as a crucial step, the identification of reliable predictors of ovarian reserve. Anti-Mullerian hormone (AMH) is one of the most reliable predictors of ovarian reserve but other factors including autoimmune thyroid diseases (ATD) have been associated with reduced fertility and poor COH outcome. Aim of the present study was to evaluate the relationship between ATD and AMH, and their role on the outcome of COH.
The study group included 288 sub-fertile euthyroid women aged less than 40 years attending a single center for Reproductive Medicine. Among them, 55 were ATD-positive and 233 ATD-negative. The serum levels of AMH, FSH, LH, estradiol (E2), and TSH were measured before COH. The ratio between serum E2 concentration on the day of oocytes pick-up and the total dose of administered recombinant FSH (r-FSH) (E2/r-FSH ratio) was calculated.
The serum levels of AMH were significantly related to E2/r-FSH ratio, total dose of r-FSH and number of M II oocytes, both in ATD-positive and ATD-negative women. Within the low stratum of AMH levels, the presence of ATD did not further affect the outcome of COH. When the serum levels of AMH were in the high stratum, the presence of ATD significantly affected the E2/rFSH ratio, the total dose of r-FSH and the number of M II oocytes.
The probability of a poor response to COH is high, and independent from ATD, in women with low AMH serum levels. In women with a good ovarian reserve, as assessed by high AMH serum levels, the presence of ATD impairs the outcome of COH.</description><identifier>ISSN: 1477-7827</identifier><identifier>EISSN: 1477-7827</identifier><identifier>DOI: 10.1186/s12958-015-0103-3</identifier><identifier>PMID: 26391773</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Anti-Mullerian Hormone - blood ; Autoimmune Diseases - blood ; Autoimmune Diseases - complications ; Autoimmune Diseases - immunology ; Autoimmunity ; Autoimmunity - immunology ; Care and treatment ; Estradiol - blood ; Estrogen ; Female ; Follicle Stimulating Hormone - blood ; Hormones ; Humans ; Infertility, Female - blood ; Infertility, Female - complications ; Infertility, Female - therapy ; Luteinizing Hormone - blood ; Ovarian Reserve - physiology ; Ovulation Induction - methods ; Physiological aspects ; Reproductive Techniques, Assisted ; Retrospective Studies ; Risk factors ; Thyroid diseases ; Thyroid Gland - immunology ; Thyrotropin - blood</subject><ispartof>Reproductive biology and endocrinology, 2015-09, Vol.13 (1), p.106-106, Article 106</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2015</rights><rights>Magri et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-7099a6d3dcbbd16bea7df90e29532e99ecab1f960ea510744f0342a6c3f2ff7e3</citedby><cites>FETCH-LOGICAL-c560t-7099a6d3dcbbd16bea7df90e29532e99ecab1f960ea510744f0342a6c3f2ff7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578365/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578365/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26391773$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Magri, Flavia</creatorcontrib><creatorcontrib>Schena, Lucia</creatorcontrib><creatorcontrib>Capelli, Valentina</creatorcontrib><creatorcontrib>Gaiti, Margherita</creatorcontrib><creatorcontrib>Zerbini, Francesca</creatorcontrib><creatorcontrib>Brambilla, Emanuela</creatorcontrib><creatorcontrib>Rotondi, Mario</creatorcontrib><creatorcontrib>De Amici, Mara</creatorcontrib><creatorcontrib>Spinillo, Arsenio</creatorcontrib><creatorcontrib>Nappi, Rossella E</creatorcontrib><creatorcontrib>Chiovato, Luca</creatorcontrib><title>Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity</title><title>Reproductive biology and endocrinology</title><addtitle>Reprod Biol Endocrinol</addtitle><description>Protocols of controlled ovarian hyper-stimulation (COH) require, as a crucial step, the identification of reliable predictors of ovarian reserve. Anti-Mullerian hormone (AMH) is one of the most reliable predictors of ovarian reserve but other factors including autoimmune thyroid diseases (ATD) have been associated with reduced fertility and poor COH outcome. Aim of the present study was to evaluate the relationship between ATD and AMH, and their role on the outcome of COH.
The study group included 288 sub-fertile euthyroid women aged less than 40 years attending a single center for Reproductive Medicine. Among them, 55 were ATD-positive and 233 ATD-negative. The serum levels of AMH, FSH, LH, estradiol (E2), and TSH were measured before COH. The ratio between serum E2 concentration on the day of oocytes pick-up and the total dose of administered recombinant FSH (r-FSH) (E2/r-FSH ratio) was calculated.
The serum levels of AMH were significantly related to E2/r-FSH ratio, total dose of r-FSH and number of M II oocytes, both in ATD-positive and ATD-negative women. Within the low stratum of AMH levels, the presence of ATD did not further affect the outcome of COH. When the serum levels of AMH were in the high stratum, the presence of ATD significantly affected the E2/rFSH ratio, the total dose of r-FSH and the number of M II oocytes.
The probability of a poor response to COH is high, and independent from ATD, in women with low AMH serum levels. In women with a good ovarian reserve, as assessed by high AMH serum levels, the presence of ATD impairs the outcome of COH.</description><subject>Adult</subject><subject>Anti-Mullerian Hormone - blood</subject><subject>Autoimmune Diseases - blood</subject><subject>Autoimmune Diseases - complications</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmunity</subject><subject>Autoimmunity - immunology</subject><subject>Care and treatment</subject><subject>Estradiol - blood</subject><subject>Estrogen</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Hormones</subject><subject>Humans</subject><subject>Infertility, Female - blood</subject><subject>Infertility, Female - complications</subject><subject>Infertility, Female - therapy</subject><subject>Luteinizing Hormone - blood</subject><subject>Ovarian Reserve - physiology</subject><subject>Ovulation Induction - methods</subject><subject>Physiological aspects</subject><subject>Reproductive Techniques, Assisted</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Thyroid diseases</subject><subject>Thyroid Gland - immunology</subject><subject>Thyrotropin - blood</subject><issn>1477-7827</issn><issn>1477-7827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptkt1r3SAYxsPYWLtuf8BuhrCb3aT1I9FkF4ND2Rd0FEp3LUZfG0uiZ2oOnP9-Zqfr2jJEFP09z8urT1W9JfiUkI6fJUL7tqsxacvErGbPqmPSCFGLjornD_ZH1auUbjGmGHf8ZXVEOeuJEOy4ihufXf1jmSaITnk0hjgHD0glpNA2gnE6h4iCRWGn_hAREsQdIOfR5uq6MCEHHab0EeUR0OiMgQKFCVZRHvcxOIPUkoOb58W7vH9dvbBqSvDmbj2pfn75fH3-rb64_Pr9fHNR65bjXAvc94obZvQwGMIHUMLYHkNpmVHoe9BqILbnGFRLsGgai1lDFdfMUmsFsJPq08F3uwwzGA0-RzXJbXSzinsZlJOPb7wb5U3YyaYVHeNtMfhwZxDDrwVSlrNLGqZJeQhLkkQQ0QjaEFrQ90_Q27BEX9orVIdp29Gu-0fdqAmk8zaUuno1lZu2IS3mlK1lT_9DlWFgdrp8jnXl_JGAHAQ6hpQi2PseCZZrUOQhKLIERa5Bkaxo3j18nHvF32Sw3-FfudQ</recordid><startdate>20150921</startdate><enddate>20150921</enddate><creator>Magri, Flavia</creator><creator>Schena, Lucia</creator><creator>Capelli, Valentina</creator><creator>Gaiti, Margherita</creator><creator>Zerbini, Francesca</creator><creator>Brambilla, Emanuela</creator><creator>Rotondi, Mario</creator><creator>De Amici, Mara</creator><creator>Spinillo, Arsenio</creator><creator>Nappi, Rossella E</creator><creator>Chiovato, Luca</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150921</creationdate><title>Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity</title><author>Magri, Flavia ; Schena, Lucia ; Capelli, Valentina ; Gaiti, Margherita ; Zerbini, Francesca ; Brambilla, Emanuela ; Rotondi, Mario ; De Amici, Mara ; Spinillo, Arsenio ; Nappi, Rossella E ; Chiovato, Luca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-7099a6d3dcbbd16bea7df90e29532e99ecab1f960ea510744f0342a6c3f2ff7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Anti-Mullerian Hormone - blood</topic><topic>Autoimmune Diseases - blood</topic><topic>Autoimmune Diseases - complications</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmunity</topic><topic>Autoimmunity - immunology</topic><topic>Care and treatment</topic><topic>Estradiol - blood</topic><topic>Estrogen</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Hormones</topic><topic>Humans</topic><topic>Infertility, Female - blood</topic><topic>Infertility, Female - complications</topic><topic>Infertility, Female - therapy</topic><topic>Luteinizing Hormone - blood</topic><topic>Ovarian Reserve - physiology</topic><topic>Ovulation Induction - methods</topic><topic>Physiological aspects</topic><topic>Reproductive Techniques, Assisted</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Thyroid diseases</topic><topic>Thyroid Gland - immunology</topic><topic>Thyrotropin - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magri, Flavia</creatorcontrib><creatorcontrib>Schena, Lucia</creatorcontrib><creatorcontrib>Capelli, Valentina</creatorcontrib><creatorcontrib>Gaiti, Margherita</creatorcontrib><creatorcontrib>Zerbini, Francesca</creatorcontrib><creatorcontrib>Brambilla, Emanuela</creatorcontrib><creatorcontrib>Rotondi, Mario</creatorcontrib><creatorcontrib>De Amici, Mara</creatorcontrib><creatorcontrib>Spinillo, Arsenio</creatorcontrib><creatorcontrib>Nappi, Rossella E</creatorcontrib><creatorcontrib>Chiovato, Luca</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Reproductive biology and endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magri, Flavia</au><au>Schena, Lucia</au><au>Capelli, Valentina</au><au>Gaiti, Margherita</au><au>Zerbini, Francesca</au><au>Brambilla, Emanuela</au><au>Rotondi, Mario</au><au>De Amici, Mara</au><au>Spinillo, Arsenio</au><au>Nappi, Rossella E</au><au>Chiovato, Luca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity</atitle><jtitle>Reproductive biology and endocrinology</jtitle><addtitle>Reprod Biol Endocrinol</addtitle><date>2015-09-21</date><risdate>2015</risdate><volume>13</volume><issue>1</issue><spage>106</spage><epage>106</epage><pages>106-106</pages><artnum>106</artnum><issn>1477-7827</issn><eissn>1477-7827</eissn><abstract>Protocols of controlled ovarian hyper-stimulation (COH) require, as a crucial step, the identification of reliable predictors of ovarian reserve. Anti-Mullerian hormone (AMH) is one of the most reliable predictors of ovarian reserve but other factors including autoimmune thyroid diseases (ATD) have been associated with reduced fertility and poor COH outcome. Aim of the present study was to evaluate the relationship between ATD and AMH, and their role on the outcome of COH.
The study group included 288 sub-fertile euthyroid women aged less than 40 years attending a single center for Reproductive Medicine. Among them, 55 were ATD-positive and 233 ATD-negative. The serum levels of AMH, FSH, LH, estradiol (E2), and TSH were measured before COH. The ratio between serum E2 concentration on the day of oocytes pick-up and the total dose of administered recombinant FSH (r-FSH) (E2/r-FSH ratio) was calculated.
The serum levels of AMH were significantly related to E2/r-FSH ratio, total dose of r-FSH and number of M II oocytes, both in ATD-positive and ATD-negative women. Within the low stratum of AMH levels, the presence of ATD did not further affect the outcome of COH. When the serum levels of AMH were in the high stratum, the presence of ATD significantly affected the E2/rFSH ratio, the total dose of r-FSH and the number of M II oocytes.
The probability of a poor response to COH is high, and independent from ATD, in women with low AMH serum levels. In women with a good ovarian reserve, as assessed by high AMH serum levels, the presence of ATD impairs the outcome of COH.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26391773</pmid><doi>10.1186/s12958-015-0103-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-7827 |
| ispartof | Reproductive biology and endocrinology, 2015-09, Vol.13 (1), p.106-106, Article 106 |
| issn | 1477-7827 1477-7827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4578365 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Adult Anti-Mullerian Hormone - blood Autoimmune Diseases - blood Autoimmune Diseases - complications Autoimmune Diseases - immunology Autoimmunity Autoimmunity - immunology Care and treatment Estradiol - blood Estrogen Female Follicle Stimulating Hormone - blood Hormones Humans Infertility, Female - blood Infertility, Female - complications Infertility, Female - therapy Luteinizing Hormone - blood Ovarian Reserve - physiology Ovulation Induction - methods Physiological aspects Reproductive Techniques, Assisted Retrospective Studies Risk factors Thyroid diseases Thyroid Gland - immunology Thyrotropin - blood |
| title | Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A47%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Mullerian%20hormone%20as%20a%20predictor%20of%20ovarian%20reserve%20in%20ART%20protocols:%20the%20hidden%20role%20of%20thyroid%20autoimmunity&rft.jtitle=Reproductive%20biology%20and%20endocrinology&rft.au=Magri,%20Flavia&rft.date=2015-09-21&rft.volume=13&rft.issue=1&rft.spage=106&rft.epage=106&rft.pages=106-106&rft.artnum=106&rft.issn=1477-7827&rft.eissn=1477-7827&rft_id=info:doi/10.1186/s12958-015-0103-3&rft_dat=%3Cgale_pubme%3EA541506235%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780258288&rft_id=info:pmid/26391773&rft_galeid=A541506235&rfr_iscdi=true |